EFFECT OF RALOXIFENE ON OSTEOPOROSIS AND DISEASE ACTIVITY IN POSTMENOPAUSAL FEMALE WITH RHEUMATIC DISEASES

被引：1
|
作者：
Lee, W. S. [1 ,2 ]
Min, I. -S. [1 ,2 ]
Choi, Y. -J. [1 ,2 ]
Lee, C. -H. [3 ]
Lee, M. -S. [3 ]
Yoo, W. -H. [1 ,2 ]
机构：
[1] Chonbuk Natl Univ, Dept Internal Med, Div Rheumatol, Sch Med, Jeonju 561756, South Korea
[2] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Jeonju 561756, South Korea
[3] Wonkwang Univ, Sch Med, Dept Internal Med, Iksan, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.5035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0497
引用
收藏
页码：772 / 772
页数：1
相关论文
共 50 条
  • [31] Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis
    D. L. Kendler
    S. Palacios
    D. A. Cox
    J. Stock
    J. Alam
    S. A. Dowsett
    J. Zanchetta
    Osteoporosis International, 2012, 23 : 1091 - 1101
  • [32] Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis
    Fujita, Takuo
    Fujii, Yoshio
    Munezane, Hiromi
    Ohue, Mutsumi
    Takagi, Yasuyuki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (04) : 477 - 484
  • [33] Raloxifene hydrochloride - Treatment of osteoporosis prevention of osteoporosis treatment of postmenopausal syndrome
    不详
    DRUGS OF THE FUTURE, 2001, 26 (07) : 713 - 714
  • [34] Benefit-risk assessment of raloxifene in postmenopausal osteoporosis
    Cranney, A
    Adachi, JD
    DRUG SAFETY, 2005, 28 (08) : 721 - 730
  • [35] Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis
    Ann Cranney
    Jonathan D. Adachi
    Drug Safety, 2005, 28 : 721 - 730
  • [36] Combined use of risedronic acid and raloxifene in postmenopausal osteoporosis
    Bazarra, A
    Castro, A
    BONE, 2003, 33 (05) : S26 - S26
  • [37] Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene
    Ziller, V.
    Wetzel, K.
    Kyvernitakis, I.
    Seker-Pektas, B.
    Hadji, P.
    CLIMACTERIC, 2011, 14 (02) : 228 - 235
  • [38] Combined use of risedronic acid and raloxifene in postmenopausal osteoporosis
    Bazarra, MA
    Castro, A
    Bazarra, A
    BONE, 2003, 32 (05) : S209 - S209
  • [39] Effects of raloxifene on platelet functions in patients with postmenopausal osteoporosis
    Ertugrul, Derun Taner
    Gursoy, Alptekin
    Yucel, Muammer
    Sahin, Mustafa
    Unal, Asli Dogruk
    Pamuk, Baris
    Berberoglu, Zehra
    Ayturk, Semra
    Tutuncu, Neslihan Bascil
    Demirag, Nilgun Guvener
    PLATELETS, 2006, 17 (06) : 351 - 353
  • [40] Comparison of alendronate and raloxifene for treatment of postmenopausal osteoporosis: Results from EFFECT and EFFECT-international
    Kagan, R
    Sambrook, P
    Luckey, M
    Geusens, P
    de Papp, A
    Melton, ME
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 596 - 596
12345